haloperidol has been researched along with nociceptin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Costentin, J; Florin, S; Meunier, JC; Suaudeau, C | 2 |
| Chang, AH; King, MA; Pasternak, GW; Rossi, GC; Williams, L | 1 |
| Mathis, JP; Pasternak, GW; Rossi, GC | 1 |
| Dun, NJ; Hwang, BH; Mizoguchi, H; Nagase, H; Narita, M; Oji, DE; Tseng, LF | 1 |
| Bianchi, C; Calò, G; Guerrini, R; Marti, M; Mela, F; Morari, M | 1 |
| Mabrouk, OS; Marti, M; Morari, M | 1 |
| Biguzzi, S; Candeletti, S; Cavallo, M; Conti, C; Eleopra, R; Latini, F; Lettieri, C; Marti, M; Morari, M; Quatrale, R; Romualdi, P; Sarubbo, S; Sensi, M; Simonato, M; Zucchini, S | 1 |
13 other study(ies) available for haloperidol and nociceptin
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Nociceptin stimulates locomotion and exploratory behaviour in mice.
Topics: Animals; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Injections, Intraventricular; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Opioid Peptides; Receptors, Opioid; Stimulation, Chemical | 1996 |
Spinal analgesic activity of orphanin FQ/nociceptin and its fragments.
Topics: Analgesics; Animals; Antisense Elements (Genetics); Cloning, Molecular; Drug Synergism; Exons; Haloperidol; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Nociceptin; Nociceptin Receptor; Opioid Peptides; Peptide Fragments; Receptors, Opioid; Receptors, sigma; Spinal Cord | 1997 |
Orphan neuropeptide NocII, a putative pronociceptin maturation product, stimulates locomotion in mice.
Topics: Amino Acid Sequence; Animals; Benzazepines; Conserved Sequence; Dopamine Antagonists; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Humans; Male; Mice; Molecular Sequence Data; Motor Activity; Neuropeptides; Nociceptin; Opioid Peptides; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid | 1997 |
Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ141-157 in mice.
Topics: Amino Acid Sequence; Analgesics, Opioid; Animals; Antipsychotic Agents; Haloperidol; Injections, Intraventricular; Injections, Spinal; Mice; Mice, Inbred Strains; Molecular Sequence Data; Nociceptin; Opioid Peptides; Peptide Fragments; Receptors, Opioid | 1998 |
Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Atropine; Autoradiography; Baclofen; Binding, Competitive; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Haloperidol; Immunohistochemistry; In Vitro Techniques; Male; Membranes; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Opioid Peptides; Peptide Fragments; Propranolol; Receptors, Opioid; Somatostatin; Spinal Cord; Sulfur Radioisotopes; Yohimbine | 1999 |
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release.
Topics: Animals; Dopamine Antagonists; Dyskinesia, Drug-Induced; Glutamic Acid; Haloperidol; Male; Microdialysis; Nociceptin; Opioid Peptides; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2004 |
Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
Topics: Animals; Antipsychotic Agents; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Narcotic Antagonists; Neuropharmacology; Nociceptin; Nociceptin Receptor; Opioid Peptides; Parkinsonian Disorders; Piperidines; Receptors, Opioid; Substantia Nigra; Synaptic Transmission | 2010 |
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease.
Topics: Adrenergic Agents; Adult; Aged; Aged, 80 and over; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Disease Models, Animal; Female; Gene Expression Regulation; Haloperidol; Humans; Male; Microdialysis; Middle Aged; Nociceptin; Opioid Peptides; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Young Adult | 2010 |